Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Contato pele a pele durante a transferência da sala de parto para a unidade de terapia intensiva neonatal: impacto em bebês muito prematuros e seus pais (TRANSPAPNEO)

4 de novembro de 2026 atualizado por: University Hospital, Tours

Avaliação do contato pele a pele durante a transferência de recém-nascidos muito prematuros da sala de parto para a unidade de terapia intensiva neonatal

Developmental care are recognized as a standard of care for preterm infants in neonatal intensive care units. Regular skin-to skin contacts during the neonatal stay show short and long-term beneficial effects on preterm infants and their parents. Skin-to-skin contact provides hemodynamic and thermal stability in preterm infants. Regarding parents, skin-to-skin contact sustains the parental bonding, and reduces stress and anxiety related to hospitalization. As a result, early skin-to-skin contact has been associated with an improvement of neurological outcome in very preterm infants.

Thermal stability is crucial during the first hour of life in preterm infants. A temperature at admission in the neonatal intensive care unit below 36.5°C or above 37.2°C has been associated with an increase in neonatal morbidity and mortality.

Early skin-to-skin contact between a newborn and his/her mother in the delivery room significantly decreases the occurrence of hypothermia below 35.5°C.

The practice of skin-to-skin transfer from the delivery room is emerging in France. Pilot studies have been carried out by French neonatal teams that showed the feasibility of this practice in late-preterm, near-term and term infants. Although skin-to-skin contact routinely involves very preterm infants in neonatal intensive care units worldwide, the feasibility and safety of skin-to-skin contact during the transfer from delivery room to the neonatal unit is poorly documented in very preterm infants. Previous data of our team showed that transfer of preterm infants with non-invasive ventilation using skin-to-skin contact was feasible and safe but concerns emerged about the thermal conservation during the procedure.

The main hypothesis of this study is that skin-to skin contact during the transfer from the delivery room to the neonatal intensive care unit could prevent heat losses in preterm infants as well as the transfer in incubator. Another hypothesis is that very early skin-to-skin contact could positively influence the neonatal course and the parental experience in the neonatal care unit.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Real)

118

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Angers, França, 49000
        • CHU Angers
      • Orléans, França, 45000
        • Neonatal medicine and intensive care unit, University Hospital, Orléans
      • Toulouse, França, 31300
        • Neonatology service, University Hospital, Toulouse
      • Tours, França, 37000
        • Neonatal and paediatric service, University Hospital, Tours

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

5 meses a 7 meses (Filho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Gestational age < 34 weeks
  • Singleton pregnancy
  • Inborn birth, i.e., in the maternity ward of investigating centres
  • Need of hospitalization in the neonatal intensive care unit
  • Oral and written information of parents and written parental consent to participate in the study (by the father if the mother is unable to participate)

Exclusion Criteria:

  • Single parent or homosexual couple
  • Absence of the father in the delivery room
  • Parents not speaking French
  • Skin temperature of the newborn < 36°C at the time of randomization
  • Conditions not allowing the early skin-to-skin contact: omphalocele, gastroschisis, desquamating dermatological conditions (Harlequin syndrome, Collodion)
  • Clinical condition requiring a specific transfer mode according to the pediatrician in the delivery room
  • Parents under legal protection
  • Minor parents

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Skin-to-skin contact during the transfer between the delivery room and the neonatal care unit

Preterm infants will be transferred using a direct skin-to-skin contact with their father from the delivery room to the intensive neonatal care.

For the Skin-to-skin Contact (SSC) transfer, the bare-chested father will seat in a wheelchair. Newborns who will wear only a diaper and a cotton cap or noninvasive ventilation headgear will be placed in the kangaroo position against the father's chest to ensure direct contact with the father's skin. Preterm infants with gestational age less than 33 weeks will be wrapped with their father using plastic bags plus warmed cotton towels. More gestationally mature infants will be wrapped with only warmed cotton wraps. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure.

Comparador Ativo: Transfer in incubator between the delivery room and the neonatal care unit

Preterm infants will be transferred in an incubator set to 36°C from the delivery room to the intensive neonatal care.

In the incubator group, infants will be transferred after resuscitation in an incubator with air temperature set to 36°C. The newborn will be laid on his/her back in a polyethylene bag with a cap. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in the infant skin temperature due to the transfer procedure
Prazo: During the transfer procedure

Fluctuation in the infant skin temperature between the randomization in the delivery room and the admission in the neonatal intensive care unit (NICU)

During the transfer procedure

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in the infant's heart rate during the transfer procedure
Prazo: During the transfer procedure

Heart rate values during the transfer procedure

During the transfer procedure
Occurrence of bradycardia episodes in infant during the transfer procedure
Prazo: During the transfer procedure

Rapid decrease in heart rate less than 100 beats/min that lasts at least 10 secondes during the transfer procedure

During the transfer procedure
Change in the infant's oxygen saturation during the transfer procedure
Prazo: During the transfer procedure

Oxygen saturation values during the transfer procedure

During the transfer procedure
Occurrence of desaturation episodes in infant during the transfer procedure
Prazo: During the transfer procedure

Decrease in oxygen saturation less than 85% that last at least 10 secondes

During the transfer procedure
Change in the infant's fraction of inspired oxygen during the transfer procedure
Prazo: During the transfer procedure

Fraction of inspired oxygen values during the transfer procedure

During the transfer procedure
Duration of the transfer procedure
Prazo: During the transfer procedure

Time (in min) during the transfer procedure

During the transfer procedure
First Hydrogen Potential (pH) of the newborn
Prazo: First blood gas in the NICU

First assessment of pH in the neonatal intensive care unit (NICU)

First blood gas in the NICU
Carbon dioxide partial pressure (pCO2) of the newborn
Prazo: First blood gas in the NICU

First assessment of carbon dioxide partial pressure (pCO2) in the neonatal intensive care unit (NICU)

First blood gas in the NICU
Blood glucose of the newborn
Prazo: First blood glucose measurement in the NICU

First assessment of blood glucose in the neonatal intensive care unit (NICU)

First blood glucose measurement in the NICU
Occurence of hypothermia
Prazo: From admission in the neonatal intensive care unit to 30 min later

Decrease of skin temperature less than 36°C

From admission in the neonatal intensive care unit to 30 min later
Time to the first skin-to-skin contact in the neonatal care unit
Prazo: Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit

Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit

Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit
Practice of skin-to-skin contact in the neonatal intensive care unit (NICU) during the first week of life
Prazo: During the first 7 days of the stay in the neonatal care unit

Frequency of skin-to-skin contact (Postnatal day and hour), length of each skin-to-skin contact, which parent involves in each skin-to-skin contact episode.

During the first 7 days of the stay in the neonatal care unit
Quality of parental bond
Prazo: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Assessment through a maternal questionnaire: Mother-to-Infant Bonding Scale (MIBS) questionnaire (Mother-to-infant bonding scale - Taylor, 2005). Only the infant's mother will be invited to fill out this questionnaire.

2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
Parental stress
Prazo: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Parental stress assessed by Perceived Stress Scale (PSS) - Neonatal Intensive Care Unit (NICU) questionnaire (Perceived Stress Scale Neonatal Intensive Care Unit - Miles, 1993). The infant's mother and father will be invited to fill out this questionnaire.

2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
Parental post-traumatic stress disorder
Prazo: At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Parental post-traumatic stress disorder assessed by Perinatal Post traumatic stress disorder Questionnaire (PPQ) - DEMIER, 1996). The infant's mother and father will be invited to fill out this questionnaire.

At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
Infant growth: Weight
Prazo: At birth and weight at the postmenstrual age of 36 weeks

Weight at birth and at the postmenstrual age of 36 weeks

At birth and weight at the postmenstrual age of 36 weeks
Infant growth: Height
Prazo: At birth and at the postmenstrual age of 36 weeks

Height at birth and at the postmenstrual age of 36 weeks

At birth and at the postmenstrual age of 36 weeks
Infant growth: Head circumference
Prazo: At birth and at the postmenstrual age of 36 weeks

Head circumference at birth and at the postmenstrual age of 36 weeks

At birth and at the postmenstrual age of 36 weeks
Neonatal morbidity and mortality at the postmenstrual age of 36 weeks
Prazo: At the postmenstrual age of 36 weeks

Death

  • Intraventricular hemorrhage (maximal grade),
  • Periventricular leukomalacia, Necrotizing enterocolitis (> stade 2 of the Bell classification),
  • Neonatal surgery,
  • Early onset sepsis (onset before postnatal day 2 and > 3 days of intravenous antibiotherapy),
  • Late onset sepsis (Blood culture positive, number of events),
  • Number of red blood cell transfusions,
  • Duration of mechanical ventilation (days).
  • Severe bronchopulmonary dysplasia,
  • Retinopathy of prematurity that requires laser photocoagulation or intravitreal injection of proangiogenic factor,
  • Length of stay in neonatal intensive care unit (days).
At the postmenstrual age of 36 weeks
Modalities of breastfeeding
Prazo: During the NICU stay: infant postnatal day

First breastfeeding attempt in the neonatal intensive care unit (NICU)

During the NICU stay: infant postnatal day
Modalities of breastfeeding
Prazo: At the postmenstrual age of 36 weeks

Presence of complete or partial breastfeeding at the postmenstrual age of 36 weeks

At the postmenstrual age of 36 weeks
Mode of infant feeding at the postmenstrual age of 36 weeks
Prazo: At the postmenstrual age of 36 weeks

Modes of infant feeding that include breastfeeding, breastmilk given through a bottle, artificial formula

At the postmenstrual age of 36 weeks

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Self-questionnaires to study parents' experience of their infant hospitalization
Prazo: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Ancillary study: Self-questionnaires to study parents' experience of their infant hospitalization to assess stress at different times.

2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Diretor de estudo: Nolwenn CLENET, University Hospital, Tours

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

3 de maio de 2023

Conclusão Primária (Real)

10 de março de 2026

Conclusão do estudo (Real)

15 de abril de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

23 de março de 2023

Enviado pela primeira vez que atendeu aos critérios de CQ

6 de abril de 2023

Primeira postagem (Real)

19 de abril de 2023

Atualizações de registro de estudo

Última Atualização Postada (Real)

9 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

4 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • DR210297

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever